Company news
Wpd Pharmaceuticals Inc (CSE:WBIO) news
Wpd Pharmaceuticals Inc news releases on 6ix. Latest, Dec 5, 2024: WPD Pharmaceuticals : PROPOSED SHARE CONSOLIDATION OF WPD’S COMMON SHARES
Press releases & updates
WPD Pharmaceuticals : PROPOSED SHARE CONSOLIDATION OF WPD’S COMMON SHARES
December 5, 2024
WPD Pharmaceuticals : ANNOUNCES SETTLEMENT OF DEBT FOR COMMON SHARES
July 25, 2024
WPD Pharmaceuticals : REINSTATEMENT OF TRADING OF WPD'S COMMON SHARES AND ANNUAL GENERAL MEETING
May 30, 2024
WPD Pharmaceuticals : Receives Full Revocation of Cease Trade Order
May 16, 2024
WPD Pharmaceuticals : Announces Filing of Annual Financial Statements and Provides Corporate Update
May 10, 2024
WPD Pharmaceuticals : Sp. z o. o., received the second tranche of the funds
November 2, 2023
WPD Pharmaceuticals : Sp. z o. o., received the first tranche of the funds
September 8, 2023
WPD Pharmaceuticals : Polish Subsidiary Signs Investment Agreement with ACRX Investments Limited
September 1, 2023
WPD Pharmaceuticals : Announces Closing of Convertible Debenture Private Placement
June 16, 2023
WPD Pharmaceuticals : Provides a Corporate Update
November 18, 2022
WPD Pharmaceuticals Signs Annex to License Agreement with Wake Forest University Health Sciences
May 16, 2022
WPD Pharmaceuticals Signs Consortium Agreement on EuroNanoMed Project
March 7, 2022
WPD Pharmaceuticals Announces Proposed Restructuring of Polish Subsidiary
February 9, 2022
WPD Pharmaceuticals Announces Appointment of New Director
February 3, 2022
WPD Pharmaceuticals Enters into Amended and Restated Sublicense Agreement with Moleculin Biotech
January 25, 2022
WPD Pharmaceuticals’ New Discovery for Cancer Targeting Drugs is Granted Patent
January 9, 2020